News

Moderna, Inc. (NASDAQ:MRNA) today announced that it had voluntarily withdrawn the pending Biologics License Application (BLA) ...
The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded ...
Federal health officials received reports about potential cardiac inflammation effects just months after the mRNA vaccines were approved, but delayed notifying the public about them and ultimately ...
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
Since 2023, federal health officials have recommended an annual COVID-19 shot for most people, and vaccine makers have not ...
This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they are safe and effective.
The announcement, which followed the FDA setting new guidelines on COVID vaccine approvals, erased the stock’s gains from ...
U.S. health officials knew about the risks of myocarditis from COVID-19 vaccines but downplayed the concern and delayed informing the public about the risks of taking the jab—that is according to a ...
The FDA is requiring COVID vaccine makers Pfizer and Moderna to update their warnings about the possible risk of myocarditis and pericarditis.
The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...
The FDA announced yesterday that it will limit access to Covid-19 vaccines to people 65 years of age and older and others who ...
Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...